Displaying drugs 1426 - 1450 of 1789 in total
Retagliptin
Retagliptin is under investigation in clinical trial NCT02822534 (The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients).
Investigational
KC706
KC706 is a novel anti-inflammatory drug that works by inhibiting the activity of p38 MAP kinase. KC706 holds potential to treat inflammatory conditions such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and cardiovascular disease.
Investigational
4-Androstenediol
Experimental
Illicit
D-Mannuronic Acid
Experimental
2-Keto-3-Deoxygluconate
Experimental
Rostafuroxin
Rostafuroxin has been used in trials studying the treatment of Essential Hypertension.
Investigational
2-phospho-D-glyceric acid
A 2-phosphoglyceric acid in which the glyceric acid moiety has D (R) configuration.
Experimental
Dalantercept
Dalantercept is under investigation in clinical trial NCT00996957 (Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma).
Investigational
Matched Categories: … Receptors, Transforming Growth Factor beta …
EGS21
EGS21(TM) is a beta-D-glucosylceramide (GC) compound. It is a potential therapeutic for treating immune mediated disorders. GC is a glycolipid that has been shown by Enzo scientists and collaborators to act as an anti-inflammatory agent in animal model systems, and therefore is being evaluated as an important candidate drug in...
Investigational
Matched Description: … EGS21(TM) is a beta-D-glucosylceramide (GC) compound. …
Tarenflurbil
Tarenflurbil is an investigational drug that was studied in patients with mild Alzheimer's disease. It is a selective amyloid lowering agent (SALA) that reduces levels of the toxic peptide amyloid beta 42 (Aβ42) in cultured human cells and in animal models. Aβ42 is the primary initiator of neurotoxicity and amyloid...
Investigational
Matched Description: … It is a selective amyloid lowering agent (SALA) that reduces levels of the toxic peptide amyloid beta …
N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide
Experimental
XL820
XL820 is investigated for use/treatment in solid tumors. XL820 is a solid. The proteins that XL820 inhibit include platelet-derived growth factor receptor beta (PDGFR), mast/stem cell growth factor receptor KIT, vascular endothelial growth factor receptor 2, and platelet-derived growth factor receptor alpha, clinically validated targets implicated in a variety of...
Investigational
Matched Description: … The proteins that XL820 inhibit include platelet-derived growth factor receptor beta (PDGFR), mast/stem …
2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid
Experimental
Tetulomab tetraxetan Lu-177
Betalutin has been used in trials studying the treatment of Non-Hodgkin Lymphoma and Relapsed, Diffuse Large B-cell Lymphoma.
Investigational
Boldenone undecylenate
Illicit
Vet approved
16-Bromoepiandrosterone
16-Bromoepiandrosterone is an injectable formulation of a compound called alpha-epi-bromide. It is a chemical relative of DHEA which was selected for development after it showed antiretroviral activity in laboratory tests.
Investigational
N-acetylmannosamine
N-acetylmannosamine is under investigation for the other of GNE Myopathy.
Investigational
CHF 4227
CHF 4227 is a new selective estrogen receptor modulator (SERM). The compound has a high receptor affinity and has shown promising efficacy in the prevention of bone loss in animal models of osteoporosis. Additionally, the compound has shown no uterotrophic activity suggesting a potential therapeutic advantage over drugs normally used...
Investigational
UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE
Experimental
Oxaloacetate Ion
Experimental
Acrylic Acid
A α,β-unsaturated monocarboxylic acid that is ethene substituted by a carboxy group.
Experimental
Furazolidone
A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone binds bacterial DNA which leads to the gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
Experimental
Vet approved
H TYPE II TRISACCHARIDE
Experimental
Displaying drugs 1426 - 1450 of 1789 in total